Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cetylpyridinium chloride 0.066% lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
|
Cetylpyridinium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
|
Cetylpyridinium chloride+ ascorbic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
|
Cetylpyridinium chloride monohydrate (substance) |
Is a |
False |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
|
Cetylpyridinium chloride monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
1 |
Cetylpyridinium chloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely benzydamine hydrochloride 1.5 milligram/1 milliliter and cetylpyridinium chloride 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 200 microgram/1 gram and chlorocresol 1 milligram/1 gram and lidocaine hydrochloride 9 milligram/1 gram conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 200 microgram/1 gram and chlorocresol 1 milligram/1 gram and lidocaine hydrochloride 9 milligram/1 gram conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cetylpyridinium chloride (substance) |
Inferred relationship |
Some |
2 |